Nadjmabadi Esmail Md Inc Bakersfield, CA - 93301

Nadjmabadi Esmail Md Inc is categorized under Internal Medicine Practitioners in Bakersfield, CA and active since 2003.

Nadjmabadi Esmail Md Inc was established in 2003, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Internal Medicine Practitioners business, which does work in the B2C market, and is classified as a Internal Medicine Practitioners, under code number 621111 by the NAICS.

If you are seeking more information, feel free to contact Esmail Nadjmabadi at the company’s single location by writing to 820 34th St # 201, Bakersfield, California CA 93301 or by phoning (661) 861-8767. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Nadjmabadi Esmail Md Inc
Contact Person: Esmail Nadjmabadi
Address: 820 34th St # 201, Bakersfield, California 93301
Phone Number: (661) 861-8767
Annual Revenue (USD): $100.000 to $499.999
Founded: 2003
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Internal Medicine Practitioners
SIC Code: 8011
NAICS Code: 621111
Share This Business:

Nadjmabadi Esmail Md Inc was started in 2003 to provide professional Internal Medicine Practitioners under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Esmail Nadjmabadi for inquiries that concern Nadjmabadi Esmail Md Inc by calling the company number (661) 861-8767, as your correspondence is most welcome. Additionally, the physical location of the single location of Nadjmabadi Esmail Md Inc can be found at the coordinates 35.390645,-119.0116 as well as the street address 820 34th St # 201 in Bakersfield, California 93301.

For its online presence, you may visit Nadjmabadi Esmail Md Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.